About James Symons, MS, PhD

 
1626

James Symons, MS, PhD, is VP of Clinical Development at Sermonix. Dr. Symons was the global clinical lead for the lasofoxifene development program for VVA as well as for multiple women’s health submissions to the FDA during his tenure at Pfizer and Parke-Davis. Recently, Jim was VP of drug development at Sprout Pharmaceutical and Meditrina Pharmaceuticals. He received his PhD in epidemiology from The University of Michigan. To view the complete CV, please click here.